XML 25 R10.htm IDEA: XBRL DOCUMENT

Other Current Assets	9 Months Ended
Other Current Assets	Sep. 30, 2019
Other Current Assets
Other Current Assets	4.Other Current Assets As of September 30, 2019, Other Current Assets included prepaid expenses of $0.7 million, comprised primarily of prepayments made for our clinical trials for prexigebersen in AML and CML of $0.4 million and prepaid insurance of $0.3 million. As of December 31, 2018, Other Current Assets included prepaid expenses of $0.8 million, comprised primarily of prepayments made for our clinical trial for prexigebersen in AML of $0.6 million, prepaid insurance of $0.1 million and other prepaid expenses of $0.1 million.